The latest biotech news

10486567 10152342154846513 5707030158597204448 o

News and Trends 18 Oct 2014

One Week European Biotech Industry Celebration

The European Biotech Week was celebrated for the second time at the beggining of October. It was an important event to discuss and develop biotechnology in Europe. The European Biotech Week was organized by EuropaBio, european organization for Biotech companies. It was also an opportunity to bring together biotech associations because they are key in helping to […]

October 18, 2014 - 1 minutemin - By Julie Lellouche

News and Trends 17 Oct 2014

Should European Biotech CEOs wear more sneakers?

Today is Friday or Casual Day. Did you leave the suit and the tie at home to wear jeans and sneakers? Should you have done so? More and more people do so on Friday but also the rest of the week. The American Tech industry and the Silicone Valley started the movement. Steve Jobs is probably the most […]

October 17, 2014 - 3 minutesmins - By Philip Hemme

News and Trends 16 Oct 2014

A Smart Collaboration to Diagnostic and Fight Cancer

New Oncology announced that it has entered into a collaboration agreement with Gustave Roussy Cancer Campus, Paris. Under this agreement, New Oncology (Cologne-based German Biotech company) will perform comprehensive parallel multigene testing to identify therapeutically relevant alterations in cancer-related genes. New Oncology will apply its proprietary diagnostic platform ‘NEO’, which allows rapid sample processing compatible with both […]

October 16, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 15 Oct 2014

New Peptide Technology Against Cancer bags 25 Million Euros

Bicycle Therapeutics, a next generation biotherapeutics UK-based company developing first-in-class bicyclic peptides, announced that it had secured an equity financing of €25 million for the clinical development of therapeutic bicycle drug candidates in oncology. Bicycle has used its proprietary bicyclic peptide technology that enables to discover a new class of drug candidates, which have similar selectivity […]

October 15, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 15 Oct 2014

Recently Launched Company Rigontec already Raised 9,45M Euros against Cancer

Rigontec GmbH, a German privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, announced the first closing of its Series A financing round, raising €9.45 million. Rigontec was launched in January 2014 as a spin-out of the Institute for Clinical Chemistry and Clinical Pharmacology at the University of Bonn, Germany. The Company’s […]

October 15, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 13 Oct 2014

Future Organ-on-a-chip Global Leader MIMETAS raised 4 Million euros

Dutch biotech MIMETAS B.V. announces that it has raised 4 Million euros ($5.2M) to fund its expansion as a global leader in organ-on-a-chip technology. Venture capital investors Zeeuws Investerings Fonds (ZIF) and Participatiemaatschapij Oost Nederland (PPM Oost) have joined forces with national and regional partners, to fund development and sales of MIMETAS’ unique 3D disease- […]

October 13, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 11 Oct 2014

ARTES Biotechnology, instrAction and Q-Biologicals Join Forces for Veterinary Vaccine Development

ARTES Biotechnology, InstrAction and Q-Biologicals establish a three-party consortium for vaccine developments for veterinary applications. Nowadays virus-like particles (VLPs) have become a widely used vehicle for the development of vaccines used in humans. Without being infectious, the particles are used to transport foreign antigens in an ideal way to the immune system. For veterinary applications, the applied VLP production […]

October 11, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 10 Oct 2014

How Gilead’s Hepatitis C Treatment challenges European Public Health Systems

American Biotech company Gilead is selling its new drug Sovaldi since 2013, which brings significant breakthrough in Hepatitis C treatment. The high cost of the drug, up to €100 000, is a challenge for european Public Health system which tries to lower its overall cost for their public health system. Hepatitis C is an infectious disease […]

October 10, 2014 - 3 minutesmins - By Philip Hemme

Oral Insulin All Mouth or an Injection of Hope for Type 1 Diabetes medium vga

News and Trends 8 Oct 2014

Once a Week Insulin Shot : Novo Nordisk’s new Idea

Denmark’s Novo Nordisk, the world’s largest insulin seller, is betting on a new way to stay ahead in the $40 billion-plus diabetes market by trying to develop the world’s first once-weekly insulin injection. Almost 592 million people are expected to live with diabetes by 2035, up 55 percent from last year’s level, according to the International Diabetes […]

October 8, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 8 Oct 2014

Baden-Württemberg Healthcare Industry Forum 2014, discover one of the largest cluster in Germany

Last September 24th was held the Baden-Württemberg Healthcare Industry Forum 2014, organized by BIOPRO the biotech cluster of this German region. It was an opportunity to review the bilan of the cluster and to learn interesting facts. BIOPRO has listed 159 biotech companies in the Baden-Württemberg area, representing a workforce of more than 22,000 employees and a turnover […]

October 8, 2014 - 6 minutesmins - By Joachim Eeckhout

LoneStar Heart Hydrogel advanced heart attacks

News and Trends 4 Oct 2014

A Hydrogel to treat Advanced Heart Failure in Europe

LoneStar Heart, Inc. announced that it received the CE Mark (European Conformity) for its Algisyl-LVR® hydrogel implant,a product for the treatment of advanced heart failure (HF). The CE Mark indicates a product’s compliance with European Union legislation and that it can be sold throughout the European Economic Area. Classified in Europe and in the U.S. as a medical device, Algisyl-LVR is […]

October 4, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 3 Oct 2014

A new way to develop therapeutic monoclonal antibodies against Cancer

Up to now, a vast majority of antibodies targets proteins. Why not targeting something else? ImmuSmol, a start-up based in Bordeaux South of France is developing monoclonal antibodies against small molecules involved in tumor immune escape. This French start-up has just raised €500k to complete its preclinical proof-of-concept. Bordeaux is one of the biggest wine […]

October 3, 2014 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

One Week European Biotech Industry Celebration

Should European Biotech CEOs wear more sneakers?

A Smart Collaboration to Diagnostic and Fight Cancer

New Peptide Technology Against Cancer bags 25 Million Euros

Recently Launched Company Rigontec already Raised 9,45M Euros against Cancer

Future Organ-on-a-chip Global Leader MIMETAS raised 4 Million euros

ARTES Biotechnology, instrAction and Q-Biologicals Join Forces for Veterinary Vaccine Development

How Gilead’s Hepatitis C Treatment challenges European Public Health Systems

Once a Week Insulin Shot : Novo Nordisk’s new Idea

Baden-Württemberg Healthcare Industry Forum 2014, discover one of the largest cluster in Germany

A Hydrogel to treat Advanced Heart Failure in Europe

A new way to develop therapeutic monoclonal antibodies against Cancer

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!